CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
603466 Shanghai Fengyuzhu Culture Technology
- 10.43
- +0.16+1.56%
Market Closed Apr 30 15:00 CST
6.20BMarket Cap-77.26P/E (TTM)
10.57High10.31Low214.23KlotVolume10.38Open10.27Pre Close223.31MTurnover3.60%Turnover RatioLossP/E (Static)594.79MShares13.2852wk High2.80P/B6.20BFloat Cap6.4952wk Low11.30Limit Up594.79MShs Float24.12Historical High9.24Limit Down2.53%Amplitude3.79Historical Low0.20Dividend TTM10.42Avg Price105.01KlotAsk1.92%Div YieldTTM100Lot Size101.69KlotBid
Shanghai Fengyuzhu Culture Technology Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 29.81%382.3M | -41.44%1.38B | -47.94%958.32M | -37.91%578.18M | -30.29%294.52M | 39.75%2.35B | 44.11%1.84B | 67.88%931.18M | 74.78%422.49M | -42.79%1.68B |
| Operating revenue | 29.81%382.3M | -41.44%1.38B | -47.94%958.32M | -37.91%578.18M | -30.29%294.52M | 39.75%2.35B | 44.11%1.84B | 67.88%931.18M | 74.78%422.49M | -42.79%1.68B |
| Other operating revenue | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
| Total operating cost | 9.73%319.48M | -32.10%1.33B | -37.71%945.44M | -17.78%622.09M | -9.99%291.14M | 31.09%1.96B | 34.43%1.52B | 38.62%756.61M | 37.53%323.47M | -35.76%1.49B |
| Operating cost | 15.49%261.93M | -37.02%1.06B | -43.39%748.2M | -23.76%482.74M | -13.97%226.8M | 37.34%1.68B | 40.82%1.32B | 46.66%633.19M | 43.80%263.64M | -37.82%1.23B |
| Operating tax surcharges | -10.06%2.21M | 24.75%10.72M | 7.43%6.76M | 12.02%4.15M | 24.56%2.45M | -1.85%8.59M | 21.65%6.29M | -4.34%3.7M | 65.19%1.97M | -47.88%8.75M |
| Operating expense | -23.26%15.53M | -7.48%83.62M | -0.64%64.64M | 12.80%47.08M | -17.05%20.24M | -11.43%90.39M | -15.73%65.06M | -7.44%41.74M | 23.91%24.4M | -28.57%102.05M |
| Administration expense | -11.07%24.87M | 0.99%104.44M | 1.71%75.17M | 12.96%53.1M | 25.21%27.97M | 13.08%103.42M | 8.62%73.91M | 21.20%47M | 9.91%22.34M | -24.20%91.45M |
| Financial expense | 1,233.28%3.45M | 250.59%7.62M | 167.00%4.16M | 128.94%1.04M | 108.51%258.66K | -7.50%-5.06M | 30.74%-6.2M | 55.03%-3.59M | 47.59%-3.04M | 79.90%-4.71M |
| -Interest expense (Financial expense) | 27.47%7.43M | 4.28%23.83M | 3.90%17.64M | 3.80%11.7M | 3.60%5.83M | 36.56%22.85M | 51.65%16.98M | 97.24%11.27M | 1,821.14%5.63M | 3,509.24%16.73M |
| -Interest Income (Financial expense) | 21.28%-4.55M | 41.48%-17.02M | 40.27%-14.26M | 29.16%-11.04M | 36.20%-5.78M | -26.22%-29.09M | -13.48%-23.87M | -10.90%-15.58M | -46.85%-9.05M | 8.59%-23.05M |
| Research and development | -14.44%11.48M | -18.85%64.26M | -18.49%46.52M | -1.67%33.98M | -5.24%13.42M | 10.28%79.18M | 16.43%57.07M | 0.68%34.56M | -13.94%14.16M | -27.63%71.8M |
| Credit Impairment Loss | -6.79%-21.76M | -9.70%-175.46M | 6.74%-140.92M | 10.82%-86.88M | 48.36%-20.37M | -3.49%-159.94M | 3.51%-151.1M | -0.34%-97.42M | -145.09%-39.45M | -6.90%-154.55M |
| Asset Impairment Loss | 261.78%2.16M | -80.72%-26.79M | 69.76%-3.93M | 64.01%-3.62M | 83.59%-1.33M | -58.57%-14.82M | -40.41%-13M | 20.53%-10.06M | -67.25%-8.13M | -903.44%-9.35M |
| Other net revenue | 27.98%-15.13M | -183.96%-208.59M | -81.78%-153.07M | -155.18%-114.95M | 53.54%-21M | 33.82%-73.46M | 38.09%-84.21M | 56.64%-45.05M | -141.63%-45.21M | -8.97%-111M |
| Fair value change income | 4,767.92%1.06M | -158.72%-35.51M | -141.83%-26.69M | -149.71%-27.77M | -101.32%-22.75K | 225.55%60.47M | 1,494.81%63.81M | 1,126.07%55.86M | 343.47%1.72M | -18.02%18.58M |
| Invest income | 215.71%1.98M | -38.67%18.63M | 6.45%7.98M | -34.61%3.84M | 120.05%625.72K | 106.97%30.38M | 8.09%7.5M | 458.09%5.87M | -83.79%284.36K | 139.30%14.68M |
| -Including: Investment income associates | 99.28%-5.14K | 34.49%5.32M | 195.88%2.3M | -29.72%127.42K | -2,814.45%-711.97K | 157.61%3.96M | 174.83%776K | 114.56%181.3K | 97.54%-24.43K | -44.24%1.54M |
| Asset deal income | ---- | ---- | ---- | ---- | ---- | --30.11K | --30.11K | --30.11K | ---- | ---- |
| Other revenue | 1,308.00%1.44M | 1.07%10.54M | 22.65%10.49M | -177.83%-526.12K | -72.15%102K | -46.93%10.43M | -54.75%8.56M | 167.73%676.02K | 251.19%366.29K | 54.45%19.64M |
| Operating profit | 370.73%47.7M | -151.33%-162.9M | -158.66%-140.18M | -222.65%-158.86M | -132.74%-17.62M | 317.47%317.33M | 1,824.72%238.98M | 236.28%129.52M | 541.69%53.81M | -85.12%76.01M |
| Add:Non operating Income | 663,406.15%4.31K | 91.89%134.55K | 76.77%134.55K | -97.50%602.3 | -100.00%0.65 | 655.37%70.12K | 1,193.91%76.12K | 310.02%24.11K | 5,157.19%31.61K | -42.68%9.28K |
| Less:Non operating expense | 1,935.27%121.45K | 120.18%877.31K | 519.89%811.34K | 444.04%710.69K | -87.05%5.97K | 411.55%398.46K | 1,646.94%130.88K | 12,963.08%130.63K | -91.51%46.07K | -98.08%77.89K |
| Total profit | 369.97%47.59M | -151.62%-163.64M | -158.96%-140.86M | -223.30%-159.57M | -132.76%-17.63M | 317.41%317M | 1,824.53%238.93M | 236.18%129.42M | 522.77%53.8M | -85.02%75.94M |
| Less:Income tax cost | 379.90%7.31M | -181.39%-28.2M | -179.11%-23.74M | -266.56%-25.27M | -126.99%-2.61M | 249.95%34.64M | 27,859.26%30.01M | 168.84%15.17M | 216.31%9.68M | -85.45%9.9M |
| Net profit | 368.25%40.27M | -147.97%-135.44M | -156.06%-117.12M | -217.56%-134.3M | -134.03%-15.01M | 327.53%282.36M | 1,597.50%208.92M | 256.51%114.24M | 379.49%44.12M | -84.95%66.04M |
| Net profit from continuing operation | 368.25%40.27M | -147.97%-135.44M | -156.06%-117.12M | -217.56%-134.3M | -134.03%-15.01M | 327.53%282.36M | 1,597.50%208.92M | 256.51%114.24M | --44.12M | -84.95%66.04M |
| Less:Minority Profit | ---- | 25.32%-314.84 | -136.61%-223.22 | -374.91%-227.1 | 2.21%-27.94 | -339.80%-421.57 | -122.36%-94.34 | 84.84%-47.82 | 84.44%-28.57 | 111.17%175.8 |
| Net profit of parent company owners | 368.25%40.27M | -147.97%-135.44M | -156.06%-117.12M | -217.56%-134.3M | -134.03%-15.01M | 327.53%282.36M | 1,597.56%208.92M | 256.51%114.24M | 379.49%44.12M | -84.95%66.04M |
| Earning per share | ||||||||||
| Basic earning per share | 800.00%0.07 | -148.94%-0.23 | -157.14%-0.2 | -221.05%-0.23 | -114.29%-0.01 | 327.27%0.47 | 1,066.67%0.35 | 211.76%0.19 | 275.00%0.07 | -84.93%0.11 |
| Diluted earning per share | 800.00%0.07 | -148.94%-0.23 | -157.14%-0.2 | -221.05%-0.23 | -114.29%-0.01 | 327.27%0.47 | 1,066.67%0.35 | 211.76%0.19 | 275.00%0.07 | -84.93%0.11 |
| Other composite income | ||||||||||
| Total composite income | 368.25%40.27M | -147.97%-135.44M | -156.06%-117.12M | -217.56%-134.3M | -134.03%-15.01M | 327.53%282.36M | 1,597.50%208.92M | 256.51%114.24M | 379.49%44.12M | -84.95%66.04M |
| Total composite income of parent company owners | 368.25%40.27M | -147.97%-135.44M | -156.06%-117.12M | -217.56%-134.3M | -134.03%-15.01M | 327.53%282.36M | 1,597.56%208.92M | 256.51%114.24M | 379.49%44.12M | -84.95%66.04M |
| Total composite income of minority owners | ---- | 25.32%-314.84 | -136.61%-223.22 | -374.91%-227.1 | 2.21%-27.94 | -339.80%-421.57 | -122.36%-94.34 | 84.84%-47.82 | 84.44%-28.57 | 111.17%175.8 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.